$265 Billion Biotechnology Services Markets - Global Analysis & Forecasts, COVID-19 Impact and Recovery to 2025 & 2030
June 01, 2021 05:08 ET
|
Research and Markets
Dublin, June 01, 2021 (GLOBE NEWSWIRE) -- The "Biotechnology Services Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering....
Outlook on the $455+ Billion Physical, Engineering and Life Sciences Global Market to 2030 - Identify Growth Segments for Investment
May 28, 2021 05:13 ET
|
Research and Markets
Dublin, May 28, 2021 (GLOBE NEWSWIRE) -- The "Physical, Engineering, and Life Sciences Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to...
PDS Biotechnology Establishes Partnership With Head and Neck Cancer Alliance
May 27, 2021 07:30 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., May 27, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a novel therapy for HPV-associated cancer based...
Novartis and Molecular Partners announce start of EMPATHY clinical trial for ensovibep for the treatment of COVID-19
May 27, 2021 01:15 ET
|
Novartis Pharma AG
EMPATHY global multi-center Phase 2 - 3 study, recruiting patients with COVID-19 infection, aiming to prevent worsening symptoms and hospitalizationThe study plans to enroll 2100 patients, with 400...
Global Cell-Based Assays Market (2021 to 2026) - by Product & Service, Application, End-user and Geography
May 25, 2021 04:53 ET
|
Research and Markets
Dublin, May 25, 2021 (GLOBE NEWSWIRE) -- The "Cell-Based Assays Market Based on Product & Service, Application, End-User, and Geography - Global Forecast up to 2026" report has been added to...
PDS Biotech Announces Release of Abstract for PDS0101 in NCI-Led Phase 2 Clinical Study for Oral Presentation at 2021 ASCO Meeting
May 20, 2021 08:00 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., May 20, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s...
Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies
May 13, 2021 08:00 ET
|
Certara
PRINCETON, N.J., May 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), the global leader in biosimulation, today announced the launch of new versions of its Immunogenicity (IG) and...
PDS Biotechnology Announces Participation in Noble Capital Markets C-Suite Interview Series
May 12, 2021 08:00 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease...
Protocol Complexity and Patient Enrollment Intensify Challenges in Oncology Clinical Trials, According to Tufts Center for the Study of Drug Development
May 04, 2021 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, May 04, 2021 (GLOBE NEWSWIRE) -- Increasing complexity of clinical trials targeting cancer—including use of more sophisticated scientific designs, larger global scope, and greater focus on...
In Vivo Toxicology Market worth $ 7.34 Billion, Globally, by 2028 at 5.31 % CAGR: Verified Market Research™
May 03, 2021 10:15 ET
|
Verified Market Research
Jersey City, New Jersey, May 03, 2021 (GLOBE NEWSWIRE) -- Verified Market Research recently published a report, “In Vivo Toxicology Market” by Testing Facility (Out-Source and In-House Testing...